Hostname: page-component-7c8c6479df-995ml Total loading time: 0 Render date: 2024-03-28T19:44:04.722Z Has data issue: false hasContentIssue false

The natural history of tolerance to the benzodiazepines

Published online by Cambridge University Press:  09 July 2009

Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Monograph
Copyright
Copyright © Cambridge University Press 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abernethy, D. R., Greenblatt, D. J., Morse, D. S. & Shader, R. I. (1985). Interaction of propoxyphene with diazepam, alprazolam and lorazepam. British Journal of Clinical Pharmacology 19, 5157.CrossRefGoogle ScholarPubMed
Adam, K., Adamson, L., Brezinova, V., Hunter, W. M. & Oswald, I. (1976). Nitrazepam: lastingly effective but trouble on withdrawal. British Medical Journal i, 15581560.CrossRefGoogle Scholar
Allen, J. W., Jawad, S., Oxley, J. & Trimble, M. (1985). Development of tolerance to anticonvulsant effect of clobazam. Journal of Neurology and Neurosurgery Quarterly 48, 284285.Google ScholarPubMed
Anhalt, H. S., Young, R. & Roginsky, M. (1980). Double-blind comparison of ketozolam, diazepam, and placebo in once-a-day vs t.i.d. dosing. Journal of Clinical Psychiatry 41, 386392.Google Scholar
Anonymous. (1985 a). Lorazepam – A benzodiazepine to choose or avoid? Drug and Therapeutics Bulletin 34, 6164.Google Scholar
Anonymous. (1985 b). Some problems with benzodiazepines. Drug and Therapeutics Bulletin 23, 2123.CrossRefGoogle Scholar
Anonymous. (1986). Oral benzodiazepines as prophylaxis for epilepsy. Drug and Therapeutics Bulletin 24, 4546.CrossRefGoogle Scholar
Anonymous (1987). Treatment of benzodiazepine dependence. Lancet i, 7879.Google Scholar
Antonelle, M. & Katz, D. (1977). Lorazepam in the long-term treatment of anxiety associated with gastrointestinal disorders: An open comparison with diazepam. Clinical Therapeutics 1, 140144.Google Scholar
Aranko, K. (1985). Task-dependent development of cross-tolerance to psychomotor effects of lorazepam in man. Acta Pharmacologica et Toxicologica 56, 373381.CrossRefGoogle ScholarPubMed
Aranko, K., Mattila, M. J. & Seppala, T. (1983). Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man. British Journal of Clinical Pharmacology 15, 545552.CrossRefGoogle Scholar
Aranko, K., Mattala, M. J., Seppala, T. & Aranko, S. (1985 a). The contribution of the metabolites to the tolerance developing to diazepam in man: Relationship to bioassayed serum benzodiazepine levels. Medical Biology 62, 277284.Google Scholar
Aranko, K., Mattila, M. J. & Bordignon, D. (1985 b). Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase. Acta Pharmacologica et Toxicologica 56, 364372.CrossRefGoogle ScholarPubMed
Aranko, K., Seppala, T., Pelliner, J. & Mattila, M. J. (1985 c). Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses. European Journal of Clinical Pharmacology 28, 559565.CrossRefGoogle ScholarPubMed
Ashton, H. (1984). Benzodiazepine withdrawal: An unfinished story. British Medical Journal 288, 11351140.CrossRefGoogle ScholarPubMed
Ayd, F. J. (1979). Benzodiazepines: Dependence and withdrawal. Journal of the American Medical Association 242, 14011402.CrossRefGoogle ScholarPubMed
Baldessarini, R. J. (1986). Chemotherapy in Psychiatry: Principles and Practice Harvard University Press: London.Google Scholar
BNF. (1986). British National Formulary British Medical Association and the Pharmaceutical Society of Great Britain: London.Google Scholar
Ballenger, J. C. (1984). Psychopharmacology of the anxiety disorders. Psychiatric Clinics of North America 7, 757771.CrossRefGoogle ScholarPubMed
Barnard, E. A., Stephenson, F. A., Sigel, E., Mamalaki, C. & Bilbe, G. (1984). The purified GABA/benzodiazepine complex: Retention of multiple functions. Neuropharmacology 23, 813814.CrossRefGoogle Scholar
Barsky, A. J. & Klerman, G. L. (1983). Overview: Hyochondriasis, bodily complaints, and somatic styles. The American Journal of Psychiatry 140, 273283.Google Scholar
Berlin, R. M. & Conell, L. J. (1983). Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: A case report. American Journal of Psychiatry 140, 488490.Google ScholarPubMed
Bond, A. & Lader, M. (1974). The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 47, 211218.CrossRefGoogle Scholar
Bond, A. & Lader, M. (1981). After effects of sleeping drugs. InPsychopharmacology of Sleep (ed. Wheatley, D.), pp. 177197. Raven Press: New York.Google Scholar
Bond, A. & Lader, M. (1982). A comparison of the psychotropic profiles of tofisopam and diazepam. European Journal of Clinical Pharmacology 22, 137142.CrossRefGoogle ScholarPubMed
Bond, A., Lader, M. & Shrotriya, R. (1983). Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG. European Journal of Clinical Pharmacology 24, 463467.CrossRefGoogle ScholarPubMed
Bosmann, H. B., Case, R. & Di Stefano, P. (1977). Diazepam receptor characterization: Specific binding of a benzodiazepine to macromolecules in various areas of rat brain. FEBS Letters 82, 368372.CrossRefGoogle ScholarPubMed
Bowden, C. L. & Fisher, J. G. (1980). Safety and efficacy of long-term benzodiazepine therapy. Southern Medical Journal 73, 15811584.CrossRefGoogle Scholar
Braestrup, C. & Nielsen, M. (1982). Neurotransmitters and CNS disease. Lancet i, 10301034.CrossRefGoogle Scholar
Braestrup, C. & Nielsen, M. (1985). Benzodiazepine receptors. Clinical Neuropharmacology 8, s2s7.CrossRefGoogle ScholarPubMed
Braestrup, C. & Squires, R. F. (1977). Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)-diazepam binding. Proceedings of the National Academy of Sciences of the USA 74, 38053809.CrossRefGoogle Scholar
Braestrup, C. & Squires, R. F. (1978). Pharmacological characterization of benzodiazepine receptors in the brain. European Journal of Pharmacology 48, 263270.CrossRefGoogle ScholarPubMed
Braestrup, C., Albrechtsen, R. & Squires, R. F. (1977). High densities of benzodiazepine receptors in human cortical areas. Nature 269, 702704.CrossRefGoogle ScholarPubMed
Braestrup, C., Nielsen, M. & Squires, R. F. (1979). No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sciences 24, 347350.CrossRefGoogle ScholarPubMed
Breimer, D. D., Jochemsen, R. & von Albert, H. H. (1980). Pharmacokinetics of benzodiazepines: Short-acting versus long-acting. Arzneimittelforschung 30, 875881.Google ScholarPubMed
Brosan, L., Broadbent, D., Nutt, D. & Broadbent, M. (1986). Performance effects of diazepam during and after prolonged administration. Psychological Medicine 16, 561571.CrossRefGoogle ScholarPubMed
Busto, U. & Sellers, E. M. (1986). Pharmacokinetic determinants of drug abuse and dependence: a conceptual perspective. Clinical Pharmacokinetics 11, 144153.CrossRefGoogle ScholarPubMed
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M. Sykora, K. (1986). Withdrawal reaction after long term therapeutic use of benzodiazepines. New England Journal of Medicine 315, 854859.CrossRefGoogle ScholarPubMed
Carskadon, M. A., Seidel, W. F., Greenblatt, D. J. & Dement, W. C. (1982). Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 5, 361371.CrossRefGoogle ScholarPubMed
Chiu, T. H. & Rosenberg, H. C. (1978). Reduced diazepam binding following chronic benzodiazepine treatment. Life Sciences 23, 11531158.CrossRefGoogle ScholarPubMed
Cohn, J. B. & Wilcox, C. S. (1984). Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder. Pharmacology 4, 9398.Google ScholarPubMed
Cook, P., Flanagan, R. & James, M. (1984). Diazepam tolerance: Effect of age, regular sedation, and alcohol. British Medical Journal 289, 351353.CrossRefGoogle ScholarPubMed
Corfield-Sumner, P. K. & Stolerman, I. P. (1978). Behavioural tolerance. In Contemporary Research in Behavioural Pharmacology (ed. Blackman, D. E. and Sanger, D. J.), pp. 391448. Plenum Press: New York.CrossRefGoogle Scholar
Costa, E. (1985). Benzodiazepine/GABA interactions: A model to investigate the neurobiology of anxiety. In Anxiety and the Anxiety Disorders (ed. Tuma, A. H. and Maser, J.), pp. 2752. Lawrence Erlbaum: Hillsdale, New Jersey.Google Scholar
Costa, E., Guidotti, A. & Mao, C. C. (1975). Evidence for the involvement of GABA in the action of benzodiazepines: Studies on rat cerebellum. In Mechanisms of Action of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 121156. Raven Press: New York.Google ScholarPubMed
Costa, E., Guidotti, A. & Toffano, G. (1978). Molecular mechanisms mediating the action of diazepam on GABA receptors. British Journal of Psychiatry 133, 239248.CrossRefGoogle ScholarPubMed
Costa, E., Corda, M. G. & Guidotti, A. (1983). On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives. Neuropharmacology 22, 14811492.CrossRefGoogle ScholarPubMed
Covi, L., Lipman, R. S., Pattison, J. H., Derogatis, L. R. & Uhlenhuth, E. H. (1973). Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatrica Scandinavica 49, 5164.CrossRefGoogle ScholarPubMed
Crawley, J. N., Marangos, P. J., Stivers, J. & Goodwin, F. K. (1982). Chronic clonazepam administration induces benzodiazepine receptor subsensitivity. Neuropharmacology 21, 8589.CrossRefGoogle ScholarPubMed
Crown, S. & Crisp, A. H. (1979). Manual of the Crown–Crisp Experiential Index. Hodder and Stoughton: London.Google Scholar
Curry, S. H. & Whelpton, R. (1979). Pharmacokinetics of closely related benzodiazepines. British Journal of Clinical Pharmacology 8, 15S21S.CrossRefGoogle ScholarPubMed
Dafters, R. & Anderson, G. (1982). Conditional tolerance to the tachycardia effect of ethanol in humans. Psychopharmacology 78, 365367.CrossRefGoogle Scholar
Dasberg, H. H., Van Der Kleijn, E., Gvelen, P. J. R. & Van Praag, H. (1974). Plasma concentrations of diazepam and of its metabolite n-desmethyl-diazepam in relation to anxiolytic effect. Clinical Pharmacology and Therapeutics 15, 473483.CrossRefGoogle Scholar
Davidoff, R. S. (1973). Alcohol and presynaptic inhibition in an isolated spinal cord preparation. Archives of Neurology 28, 6063.CrossRefGoogle Scholar
Demellweek, C. & Goudie, A. J. (1983). Behavioural tolerance to amphetamine and other psychostimulants: The case for considering behavioural mechanisms. Psychopharmacology 80, 287307.CrossRefGoogle ScholarPubMed
Department of Health and Social Security. (1984). Guidelines of Good Clinical Practice in the Treatment of Drug Misuse, Report of the Medical Working Group on Drug Dependence, Elephant and Castle, London.Google Scholar
Di Stefano, P., Case, K. R., Costello, G. D. & Bosmann, H. B. (1979). Increased specific binding of 3H-diazepam in rat brain following chronic diazepam administration. Cellular Biology International Report 3, 163167.CrossRefGoogle Scholar
Dixon, N. F. (1981). Preconscious Processing. Wiley: Chichester.Google Scholar
Dodson, A. & Young, G. (1982). Fluctuations in plasma lorazepam levels during the first six hours after oral administration, Proceedings of the British Pharmacological Society,1st–2nd April 1982. British Journal of Clinical Pharmacology 14, 141P.Google Scholar
Eberts, F. S. (1974). Comparative metabolism of triazolam, a new sedative-hypnotic, in rat, dog and man. Pharmacologist 16, 196199.Google Scholar
Eberts, F. S. (1977). Disposition of triazolam. Pharmacologist 19, 165170.Google Scholar
Eberts, F. S., Philopoulos, Y., Reineke, L. M. & Vliek, R. W. (1981). Triazolam disposition. Clinical Pharmacology and Therapeutics 29, 8193.CrossRefGoogle ScholarPubMed
Edwards, G. (1984). Addictions as Challenge to Society, the 1984 Upjohn Lecture, University of London. New Society 25 10 1984.Google Scholar
Edwards, J. G., Cantopher, T. & Olivier, S. (1984). Dependence on psychotropic drugs: an overview. Postgraduate Medical Journal 60, 2940.Google ScholarPubMed
Elass, P., Hendel, J., Hvidberg, E. F., Hansen, T., Gymoese, E. & Rathje, J. (1980). Kinetics and neuropsychologic effects of intravenous diazepam in the presence and absence of its active N-desmethyl metabolite in humans. Psychopharmacology 70, 307312.CrossRefGoogle Scholar
Ellinwood, E. H., Heatherly, D. G., Nikaido, A. M., Bjornsson, T. D. & Kilts, S. (1985). Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology 86, 302309.CrossRefGoogle ScholarPubMed
Fabre, L. F., McLendon, D. M. & Stephens, A. G. (1981). Comparison of the therapeutic effect, tolerance, and safety of ketazolam and diazepam administered for six months to out-patients with chronic anxiety. Journal of International Medical Research 9, 191198.CrossRefGoogle ScholarPubMed
File, S. E. (1981). Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology 73, 240245.CrossRefGoogle Scholar
File, S. E. (1982). Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (Ro 15–1788) on the development of tolerance. Psychopharmacology 77, 284288.CrossRefGoogle ScholarPubMed
File, S. E. (1983). Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse. Psychopharmacology 79, 284286.CrossRefGoogle Scholar
File, S. E. (1984). Behavioural pharmacology of benzodiazepines. Neuropsychopharmacology and Biological Psychiatry 8, 1931.CrossRefGoogle ScholarPubMed
File, S. E. (1985). Tolerance to the behavioural actions of benzodiazepines. Neuroscience and Biobehavioural Reviews 9, 113121.CrossRefGoogle Scholar
File, S. E. & Bond, A. J. (1979). Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology 66, 309313.CrossRefGoogle ScholarPubMed
File, S. E. & Lister, R. G. (1985). A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance. British Journal of Clinical Pharmacology 19, 445451.CrossRefGoogle ScholarPubMed
File, S. E. & Pellow, S. (1985). No cross-tolerance between the stimulatory and depressant actions of benzodiazepines in mice. Behavioural Brain Research 17, 17.CrossRefGoogle ScholarPubMed
Fonagy, P. & Higgitt, A. (1985). Personality Theory and Clinical Practice. Methuen: London.Google Scholar
Fontaine, R., Chouinard, G. & Annable, L. (1984). Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 141, 848852.Google ScholarPubMed
Frey, H.-H., Philippin, H.-P. & Scheuler, W. (1984). Development of tolerance to the anticonvulsant effect of diazepam in dogs. European Journal of Pharmacology 104, 2738.CrossRefGoogle Scholar
Fuxe, K., Agnati, L. F., Bolme, P., Hokfelt, T., Lidbrink, P., Ljungdahl, A., Mora, M. P. & Ogren, S. O. (1975). The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurones. In Mechanisms of Action of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 4561. Raven Press: New York.Google ScholarPubMed
Gallager, D. W., Gonsalves, S. F., Rauch, S. L. & Lakoski, J. M. (1984 a). Chronic benzodiazepine treatment decreases post synaptic GABA sensitivity. Nature 308, 7477.CrossRefGoogle Scholar
Gallager, D. W., Rauch, S. L. & Malcolm, A. B. (1984 b). Alterations in a low affinity GABA recognition site following chronic benzodiazepine treatment. European Journal of Pharmacology 98, 159160.CrossRefGoogle Scholar
Geller, I. & Seifter, J. (1960). The effect of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1, 482492.CrossRefGoogle Scholar
Ghonheim, M. M., Hinrichs, J. V. & Mewaldt, S. P. (1986). Comparison of two benzodiazepines with differing accumulation: behavioural changes during and after three weeks of dosing. Clinical Pharmacology and Therapeutics 39, 491500.CrossRefGoogle Scholar
Giles, H. G., MacLeod, S. M., Wright, J. R. & Sellers, E. M. (1978). Influence of age and previous use on diazepam dosage required for endoscopy. Canadian Medical Association Journal 118, 513514.Google ScholarPubMed
Goldberg, M. E., Manian, A. A. & Efron, D. H. (1967). A comparative study of certain pharmacologic responses following acute and chronic administration of chlordiazepoxide. Life Sciences 6, 481499.CrossRefGoogle ScholarPubMed
Goldberg, D. P., Kay, C. & Thompson, L. (1976). Psychiatric morbidity in general practice and the community. Psychological Medicine 6, 565569.CrossRefGoogle ScholarPubMed
Golombok, S. & Lader, M. (1984). The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects. British Journal of Clinical Pharmacology 18, 127133.CrossRefGoogle ScholarPubMed
Gorenstein, C. & Gentil, V. (1983). Residual and acute effects of flurazepam and triazolam in normal subjects. Psychopharmacology 80, 376379.CrossRefGoogle ScholarPubMed
Goudie, A. J. & Demellweek, C. (1986). Conditioning factors in drug tolerance. In Behavioural Analysis of Drug Dependence (ed. Goldberg, S. R. and Stolerman, I. P.), pp. 225276. Academic Press: London.Google Scholar
Grandison, L. (1983). Actions of benzodiazepines on the neuroendocrine system. Neuropharmacology 22, 15051510.CrossRefGoogle ScholarPubMed
Greeley, J. & Cappell, H. (1985). Associative control of tolerance to the sedative and hypothermic effects of chlordiazepoxide. Psychopharmacology 86, 487493.CrossRefGoogle Scholar
Greenblatt, D. J. (1981). Clinical pharmacokinetics of oxazepam and lorazepam. Clinical Pharmacokinetics 6, 89105.CrossRefGoogle ScholarPubMed
Greenblatt, D. J. & Shader, R. I. (1978). Dependence, tolerance and addiction to benzodiazepines: Clinical and pharmacokinetic considerations. Drug Metabolism 8, 1328.CrossRefGoogle ScholarPubMed
Greenblatt, D. J. & Shader, R. I. (1986). Long-term administration of benzodiazepines: pharmacokinetic versus pharmacodynamic tolerance. Psychopharmacology Bulletin 22, 416423.Google ScholarPubMed
Greenblatt, D. J., Shader, R. I., Harmatz, J. S. & Georgotas, A. (1979). Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepate. Psychopharmacology 66, 289290.CrossRefGoogle ScholarPubMed
Greenblatt, D. J., Allen, M. D., Harmatz, J. S. & Shader, R. I. (1980 a). Diazepam disposition determinants. Clinical Pharmacology and Therapeutics 27, 301311.CrossRefGoogle ScholarPubMed
Greenblatt, D. J., Ochs, H. R. & Lloyd, B. C. (1980 b). Entry of diazepam and its major metabolite into the cerebrospinal fluid. Psychopharmacology 70, 8993.CrossRefGoogle Scholar
Greenblatt, D. J., Laughren, T. P., Allen, T. P., Hermatz, J. S. & Shader, R. I. (1981). Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy. British Journal of Clinical Pharmacology 11, 3540.CrossRefGoogle ScholarPubMed
Greenblatt, D. J., Divoll, M., Abernethy, D. R. & Shader, R. I. (1982). Benzodiazepine hypnotics: kinetic and therapeutic options. Sleep 5, S18S27.CrossRefGoogle ScholarPubMed
Greenblatt, D. J., Shader, R. I. & Abernethy, D. R. (1983 a). Drug therapy: Current status of benzodiazepines (first of two parts). The New England Journal of Medicine 309, 354358.Google Scholar
Greenblatt, D. J., Shader, R. I. & Abernethy, D. R. (1983 b). Drug therapy: Current status of benzodiazepines (second of two parts). The New England Journal of Medicine 309, 410416.Google Scholar
Greizerstein, H. B. (1979). Development of functional tolerance to pentobarbital in goldfish. Journal of Pharmacology and Experimental Therapeutics 208, 123127.Google ScholarPubMed
Griffiths, A., Tedeschi, G., Smith, A. T. & Richens, A. (1983). The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. Paper given at British Psychological Society 5–7 January, Welsh National School of Medicine, Cardiff.Google Scholar
Grim, V. E. & Herschkowitz, M. (1981). The effect of chronic diazepam treatment on discrimination performance and 3H-flunitrazepam binding in the brain of shocked and non shocked rats. Psychopharmacology 74, 132136.CrossRefGoogle Scholar
Gross, A. J. (1977). Observations on long-term administration of lorazepam in anxiety states. An open comparison with diazepam. Current Therapy Research 22, 597604.Google Scholar
Haefely, W. (1983). The biological basis of benzodiazepine actions. Journal of Psychoactive Drugs 13, 1938.CrossRefGoogle Scholar
Haefely, W. (1984). Benzodiazepine interactions with GABA receptors. Neuroscience Letters 47, 201206.CrossRefGoogle ScholarPubMed
Haefely, W. (1985). Tranquilizers. In Psychopharmacology 2, Part 1: Preclinical Psychopharmacology, (ed. Grahame-Smith, D. G. and Cowen, P. J.) pp. 92182. Elsevier: Amsterdam.CrossRefGoogle Scholar
Haefely, W. (1986). Biological basis of drug induced tolerance, rebound and dependence: contribution of recent research on benzodiazepines. Pharmacopsychiatry 19, 353361.CrossRefGoogle ScholarPubMed
Haefely, W., Kulcsar, A. & Moehler, H. (1975). Possible involvement of GABA in the central actions of benzodiazepines. In Mechanism of Action of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 131151. Raven Press: New York.Google ScholarPubMed
Hallstrom, C. and Lader, M. (1981). Benzodiazepine withdrawal phenomena. International Pharmacopsychiatria 16, 235244.CrossRefGoogle ScholarPubMed
Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 5055.CrossRefGoogle ScholarPubMed
Harrison, M., Busto, U., Naranjo, C. A., Kaplan, H. L. & Sellers, E. M. (1984). Diazepam tapering in detoxification for high-dose benzodiazepine abuse. Clinical and Pharmacological Therapy 35, 527533.CrossRefGoogle Scholar
Haskell, D., Cole, J. O., Schniebolk, S. & Lieberman, B. (1986). A survey of diazepam patients. Psychopharmacology Bulletin 22, 434438.Google ScholarPubMed
Henauer, S., Lombrozo, L. & Hollister, L. E. (1984). Functional tolerance to alprazolam-induced neurologic deficits in mice. Life Sciences 35, 20652070.CrossRefGoogle ScholarPubMed
Hendel, J., Elass, P., Sorensen, K. H., Molter, I. W., Hvidberg, E. F. & Hansen, T. (1980). Anxiety and sedation during a stressful situation after a single dose of diazepam versus N-desmethyl diazepam – a controlled trial. Psychopharmacology 70, 303305.CrossRefGoogle Scholar
Higgitt, A. (1986). The development of tolerance to the benzodiazepines, its long-term persistence and the psychological treatment of severe benzodiazepine dependence, Unpublished M.D. Thesis, University of London.Google Scholar
Higgitt, A., Fonagy, P., Richardson, P. H., Lader, M., Rooney, G. & Mullan, N. (1986 a). The development of tolerance to placebos. Unpublished Manuscript.Google Scholar
Higgitt, A., Lader, M. & Fonagy, P. (1986 b). The effects of the benzodiazepine antagonist Ro 15–1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology 89, 395403.CrossRefGoogle ScholarPubMed
Higgitt, A., Golombok, S., Fonagy, P. & Lader, M. (1987). Group treatment of benzodiazepine dependence. British Journal of Addiction 82, 517532.CrossRefGoogle ScholarPubMed
Hillestad, L., Hanson, T. & Melsom, H. (1974). Diazepam metabolism in normal man: ii serum concentrations and clinical effect after oral administration and cumulation. Clinical Pharmacology and Therapeutics 16, 495501.CrossRefGoogle ScholarPubMed
Hinson, R. E. & Siegel, S. (1980). The contribution of Pavlovian conditioning to ethanol tolerance and dependence. In Alcohol Tolerance, Dependence and Addiction (ed. Rigter, H. and Crabbe, J. C.), pp. 8698. Elsevier/North-Holland Biomedical Press: Amsterdam.Google Scholar
Hinson, R. E. & Siegel, S. (1983). Anticipatory hyperexcitability and tolerance to the narcotizing effect of morphine in the rat. Behavioural Neuroscience 97, 759767.CrossRefGoogle Scholar
Hironaka, T., Fuchino, K. & Fujii, T. (1983). The benzodiazepine receptor and receptor tolerance produced by chronic treatment of diazepam. Japanese Journal of Pharmacology 33, 95102.CrossRefGoogle ScholarPubMed
Hoehn-Saric, R. & MacLeod, D. R. (1986). Physiological and performance responses to diazepam: two types of effects. Psychopharmacology Bulletin 22, 439443.Google ScholarPubMed
Hollister, L. E. (1981). Pharmacology and pharmacokinetics of the tranquillisers. Psychiatric Annals 2 (supplement), 2631.CrossRefGoogle Scholar
Hollister, L. E. (1983). The pre-benzodiazepine era. Journal of Psychoactive Drugs 15, 913.CrossRefGoogle ScholarPubMed
Hollister, L. E., Conley, F. K., Britt, R. H. & Shuer, L. (1981). Longterm use of diazepam. Journal of the American Medical Association 246, 15681570.CrossRefGoogle ScholarPubMed
Hommer, D. W., Matsui, V., Wolkowitz, O., Chrousos, G., Greenblatt, D. J., Weingartner, H. & Paul, S. M. (1986). Benzodiazepine sensitivity in normal human subjects. Archives of General Psychiatry 43, 542552.CrossRefGoogle ScholarPubMed
Jochemsen, R., Van der Graaff, M., Joeinjinga, J. K. & Breimer, D. D. (1982). Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam. British Journal of Clinical Pharmacology 13, 319324.CrossRefGoogle ScholarPubMed
Jochemsen, R., Vanboxtel, C. J., Hermans, J. & Breimer, D. D. (1983). Kinetics of five benzodiazepine hypnotics in healthy subjects. Clinical Pharmacology and Therapeutics 34, 4247.CrossRefGoogle ScholarPubMed
Kalant, H., Leblanc, A. E. & Gibbins, D. J. (1971). Tolerance to and dependence on some non-opiate psychotropic drugs. Pharmacological Reviews 23, 123191.Google ScholarPubMed
Kales, A. & Kales, J. D. (1983). Sleep laboratory studies of hypnotic drugs: Efficacy and withdrawal effects. Journal of Clinical Psychopharmacology 3, 140149.CrossRefGoogle ScholarPubMed
Kales, A., Kales, J. D. & Bixler, E. O. (1975). Effectiveness of hypnotic drugs with prolonged use: flurazepam and pentobarbital. Clinical Pharmacology and Therapy 18, 356363.CrossRefGoogle ScholarPubMed
Kales, A., Scharf, M. B. & Kales, J. D. (1978). Rebound insomnia: a new clinical syndrome. Science 201, 10391040.CrossRefGoogle ScholarPubMed
Kales, A., Scharf, M. B., Kales, J. D. & Soldatos, C. R. (1979). Rebound insomnia. Journal of the American Medical Association 241, 16921695.CrossRefGoogle ScholarPubMed
Kales, A., Soldatos, C. R., Bixler, E. O. & Kales, J. D. (1983). Early morning insomnia with rapidly eliminating benzodiazepines. Science 220, 9597.CrossRefGoogle ScholarPubMed
Kales, J. D., Kales, A. & Bixler, E. O. (1984). Biopsychobehavioral correlates of insomnia. V. Clinical characteristics and behavioral correlates. American Journal of Psychiatry 141, 13711376.Google ScholarPubMed
Kales, A., Soldatos, C. R. & Vela-Bueno, A. (1985). Clinical comparison of benzodiazepine hypnotics with short and long elimination half-lives. In The Benzodiazepines: Current Standards for Medical Practice, (ed. Smith, D. E. and Wesson, D. R.), pp. 121147. MTP Press: Lancaster.CrossRefGoogle Scholar
Kemper, N., Poser, W. & Poser, S. (1980). Benzodiazepinabhängigkeit Deutsche Medizinische Wochenschrift 105, 17071712.CrossRefGoogle Scholar
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C. & Beer, B. (1979). Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacology, Biochemistry and Behaviour 11, 457462.CrossRefGoogle ScholarPubMed
Koulu, M., Lammintausta, R. and Dahlstrom, S. (1979). Stimulatory effect of acute baclofen administration on human growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 48, 10381040.CrossRefGoogle ScholarPubMed
Laakmann, G., Treusch, J., Eichmeier, A., Schmauss, M., Treusch, U. & Wahlster, U. (1982). Inhibitory effect of phentolamine on diazepam-induced growth hormone secretion and lack of effect of diazepam on prolactin secretion in man. Psychoneuroendocrinology 7, 135139.CrossRefGoogle ScholarPubMed
Lacey, R. & Woodward, S. (1985). That's Life Survey on Tranquillisers. BBC Publications: London.Google Scholar
Lader, M. (1981). Benzodiazepine dependence. In The Misuse of Psychotropic Drugs (ed. Murray, P. R., Ghodse, H., Harris, C., Williams, D. and Williams, P.), pp. 1316. Gaskell: London.Google Scholar
Lader, M. H. (1984). Neurotransmitters and anxiety: Overview. Psychopathology 17, 37.CrossRefGoogle ScholarPubMed
Lader, M. H. & File, S. E. (1987). The biological basis of benzodiazepine dependence. Psychological Medicine 17, 539547.CrossRefGoogle ScholarPubMed
Lader, M. H. & Petursson, H. (1983 a). Rational use of anxiolytic/sedative drugs. Drugs 25, 514528.CrossRefGoogle ScholarPubMed
Lader, M. H. & Petursson, H. (1983 b). Abuse liability of anxiolytics. In Anxiolytics: Neurochemical, Behavioural and Clinical Perspectives (ed. Malick, J. B., Enna, S. J. and Yamamura, H. I.), pp. 201214. Raven Press: New York.Google Scholar
Lader, M. H., Curry, S. & Baker, W. J. (1980). Physiological and psychological effects of clorazepate in man. British Journal of Clinical Pharmacology 9, 8390.CrossRefGoogle ScholarPubMed
Ladewig, D. (1984). Dependence liability of the benzodiazepines. Drug and Alcohol Dependence 13, 139149.CrossRefGoogle ScholarPubMed
Lang, P. (1977). Physiological assessment of anxiety and fear. In Behavioural Assessment (ed. Cone, J. and Hawkins, R.), pp. 179195. Brunner/Mazel: New York.Google Scholar
Lapierre, Y. D. (1980). Benzodiazepine withdrawal. Canadian Journal of Psychiatry 26, 9395.CrossRefGoogle Scholar
Leblanc, A. E. & Cappel, H. (1977). Tolerance as adaptation: Interactions with behaviour and parallels to other adaptive processes. In Alcohol and Opiates (ed. Blum, K.), pp. 6577. Academic Press: New York.Google Scholar
Linnoila, M., Erwin, C. W., Brendle, A., Skinner, T. & Routledge, P. A. (1980). Pharmacodynamics and pharmacokinetics of diazepam in an abuser. Acta Pharmacologica et Toxicologica 47, 7577.CrossRefGoogle Scholar
Lippa, A. S., Nash, R. & Greenblatt, E. (1979). Pre-clinical neuropharmacological testing procedures for anxiolytic drugs. In Anxiolytics (ed. Fielding, S. and Lal, H.), pp. 4060. Pergamon Press: New York.Google Scholar
Little, H. J., Nutt, D. J. & Taylor, S. C. (1987). Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Research Bulletin 19, 371378.CrossRefGoogle ScholarPubMed
Lucki, I. & Rickels, K. (1986). The behavioural effects of benzodiazepines following long-term use. Psychopharmacology Bulletin 22, 424433.Google ScholarPubMed
Lukas, S. E. & Griffiths, R. R. (1984). Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. European Journal of Pharmacology 100, 163171.CrossRefGoogle ScholarPubMed
McMillan, D. E. & Leander, J. D. (1978). Chronic chlordiazepoxide and pentobarbital interactions on punished and unpunished behavior. Journal of Pharmacology and Experimental Therapeutics 207, 515520.Google ScholarPubMed
McNicholas, L. F., Martin, W. R. & Cherian, S. (1983). Physical dependence on diazepam and lorazepam in the dog. The Journal of Pharmacology and Experimental Therapeutics 226, 783789.Google ScholarPubMed
Maletzky, B. M. & Klotter, J. (1976). Addiction to diazepam. International Journal of Addiction 11, 95115.CrossRefGoogle ScholarPubMed
Marangos, P. J. & Crawley, J. N. (1982). Chronic benzodiazepine treatment increases [3H]muscimol binding in mouse brain. Neuropharmacology 21, 8184.CrossRefGoogle ScholarPubMed
Marks, J. (1978). The Benzodiazepines. Use, Overuse, Misuse, Abuse. MTP Press: Lancaster.Google Scholar
Marks, J. (1983). The benzodiazepines – for good or evil. Neuropsychobiology 10, 115126.CrossRefGoogle ScholarPubMed
Marks, J. (1985). Chronic anxiolytic treatment: benefit and risk. In Chronic Treatments in Neuropsychiatry (ed. Kemali, D. and Racagni, G.), pp. 3541. Raven Press: New York.Google Scholar
Martin, I. L. (1982). The benzodiazepines: recent trends. Psychological Medicine 12, 689693.CrossRefGoogle ScholarPubMed
Martin, I. L., Brown, C. L. & Doble, A. (1983). Multiple benzodiazepine receptors: structures in the brain or structures in the mind; a critical review. Life Sciences 32, 19251933.CrossRefGoogle ScholarPubMed
Martin, W. R., McNicholas, F. L. & Cherian, S. (1982). Diazepam and pentobarbital dependence in the rat. Life Sciences 31, 721730.CrossRefGoogle ScholarPubMed
Mele, L., Sagratella, S. and Massotti, M. (1984). Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA and benzodiazepine binding sites in vitro. Brain Research 323, 93102.CrossRefGoogle ScholarPubMed
Mellinger, G. D., Balter, M. B. & Uhlenhuth, E. H. (1984). Prevalence and correlates of the long-term regular use of anxiolytics. Journal of the American Medical Association 251, 375379.CrossRefGoogle ScholarPubMed
Mendelson, W. B., Goodwin, D. W. & Hill, S. Y. (1976). The morning after: residual effects of triazolam and flurazepam alone and in combination with alcohol. Current Therapeutics and Research 19, 155163.Google ScholarPubMed
Mennini, T., Gobbi, M. & Garattini, S. (1984). Increased number of brain benzodiazepine receptors after in-vivo administration of estazolam to rats. Journal of Pharmacy and Pharmacology 36, 621622.CrossRefGoogle ScholarPubMed
Miller, N. E. (1978). Biofeedback and visceral learning. Annual Review of Psychology 29, 378404.CrossRefGoogle ScholarPubMed
Moerschbaecher, J. M., Boren, J. J., Schrot, J. & Fontes, J. C. S. (1979). Effects of cocaine and d-amphetamine on the repeated acquisition of response chains. Journal of the Experimental Analysis of Behaviour 31, 127140.CrossRefGoogle Scholar
Mohler, H. & Okada, T. (1977 a). Properties of 3-H-diazepam binding to benzodiazepine receptors in rat cerebral cortex. Life Sciences 20, 21012110.CrossRefGoogle ScholarPubMed
Mohler, H. & Okada, T. (1977 b). Benzodiazepine receptor: demonstration in the central nervous system. Science 198, 849859.CrossRefGoogle ScholarPubMed
Mohler, H., Okada, T. & Enna, S. J. (1978). Benzodiazepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam and phenobarbital. Brain Research 156, 391395.CrossRefGoogle ScholarPubMed
Mohler, H., Battersby, M. K. & Richards, J. C. (1980). Benzodiazepine receptor protein identified and visualised in brain tissue by a photoaffinity label. Proceedings of the National Academy of Sciences of the U.S.A. 77, 16661670.CrossRefGoogle Scholar
Mokler, D. J. & Rech, R. H. (1985). Mechanisms of the initial treatment phenomenon to diazepam in the rat. Psychopharmacology 87, 242246.CrossRefGoogle ScholarPubMed
Morgan, K. & Oswald, I. (1982). Anxiety caused by a short-life hypnotic. British Medical Journal 284, 942.CrossRefGoogle ScholarPubMed
Morre, M., Bachy, A. & Keane, P. E. (1985). Differential CNS binding of benzodiazepines. Supplément Actualilés Médicales Internationales – Psychiatrie 2, 2832.Google Scholar
Murray, J. (1981). Long-term psychotropic drug taking and the process of withdrawal. Psychological Medicine 11, 853858.CrossRefGoogle ScholarPubMed
Naber, D. (1982). Peptides. In Psychopharmacology Part 2 (ed. Hippius, H. and Winokur, G.), pp. 162177. Excerpta Medica: Amsterdam.Google Scholar
Nelson, J. C., Jatlow, P. I. & Quinlan, D. M. (1984). Subjective complaints during desipramine treatment. Archives of General Psychiatry 41, 5559.CrossRefGoogle ScholarPubMed
O'Callaghan, J. P. & Holtzman, S. G. (1976). Prenatal administration of morphine to the rat. Journal of Pharmacology and Experimental Therapeutics 197, 533544.Google ScholarPubMed
Odell, W. D., Rayford, P. L. & Ross, G. T. (1967). Simple partially automated method for radioimmunoassay of human thyroid stimulating, growth, luteinizing and follicle stimulating hormones. Journal of Laboratory and Clinical Medicine 70, 973980.Google Scholar
Okamoto, M. & Boisse, N. R. (1975). Effect of chronic pentobarbital treatment on blood–cerebrospinal fluid kinetics. European Journal of Pharmacology 33, 205209.CrossRefGoogle ScholarPubMed
Olsen, R. W. (1982). Drug interactions at the GABA receptorionophore complex. Annual Review of Pharmacology and Toxicology 22, 245277.CrossRefGoogle ScholarPubMed
Orford, J. (1985). Excessive Appetites: A Psychological View of Addictions. Wiley: Chichester.Google Scholar
Oswald, I., French, C., Adam, K. & Gilham, J. (1982). Benzodiazepine hypnotics remain effective for 24 weeks. British Medical Journal 284, 860863.CrossRefGoogle ScholarPubMed
Pakes, G. E., Brogden, R. N., Heel, R. C., Speight, T. M. & Avery, G. S. (1981). Triazolam: A review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22, 81101.CrossRefGoogle ScholarPubMed
Patat, A. & Foulhoux, P. (1985). Effect on postural sway of various benzodiazepine tranquillizers. British Journal of Clinical Pharmacology 20, 916.CrossRefGoogle ScholarPubMed
Pennebaker, J. & Skelton, J. (1978). Psychological parameters of physical symptoms. Personality and Social Psychology Bulletin 4, 524530.CrossRefGoogle Scholar
Pennebaker, J. W. (1980). Perceptual and environmental determinants of coughing. Basic and Applied Social Psychology 1, 8391.CrossRefGoogle Scholar
Pennebaker, J. W. (1982). The Psychology of Physical Symptoms. Springer-Verlag: New York.CrossRefGoogle Scholar
Pennebaker, J. W. & Hoover, C. W. (1986). Inhibition and cognition: Toward an understanding of trauma and disease. In Consciousness and Self-regulation (ed. Davidson, R. J., Schwartz, G. E. and Shapiro, D.), pp. 107136. Plenum Press: New York.CrossRefGoogle Scholar
Petersen, E. N., Jensen, L. H., Drejer, J. & Honore, T. (1986). New perspectives in benzodiazepine receptor pharmacology. Pharmacopsychiatry 19, 46.CrossRefGoogle Scholar
Petrie, A. (1978). Individuality in Pain and Suffering 2nd edn. University of Chicago Press: Chicago.Google Scholar
Petursson, H. (1982). Clinical and Laboratory Studies of Withdrawal from Long-term Benzodiazepine Treatment. Unpublished Ph.D. thesis. University of London.Google Scholar
Petursson, H. & Lader, M. (1983). Benzodiazepine withdrawal syndrome. In New Psychiatric Syndromes: DSM III and Beyond (ed. Akhtar, S.), pp. 177190. Jason Aronson: New York.Google Scholar
Petursson, H., Shur, E., Checkley, S., Slade, A. & Lader, M. H. (1981). A neuroendocrine approach to benzodiazepine tolerance and dependence. British Journal of Clinical Pharmacology 11, 525526.CrossRefGoogle ScholarPubMed
Petursson, H., Gudjonsson, G. H. & Lader, M. H. (1983). Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology 81, 345349.CrossRefGoogle ScholarPubMed
Picton, T. W. (1980). The use of human event-related potentials in psychology. In Techniques in Psychophysiology (ed. Martin, I. and Venables, P. H.), pp. 357395. Wiley: Chichester.Google Scholar
Pinsker, H. & Sujaga-Petchal, K. (1984). Use of benzodiazepines in primary-care geriatric patients. Journal of the American Geriatrics Society 32, 595597.CrossRefGoogle ScholarPubMed
Poulos, C. X., Wilkinson, A. D. & Capped, H. D. (1981). Homeostatic regulation and pavlovian conditioning in tolerance to amphetamine-induced anorexia. Journal of Comparative and Physiological Psychology 95, 735746.CrossRefGoogle ScholarPubMed
Power, K. G., Jerrom, D. W. A., Simpson, R. J. & Mitchell, M. (1985). Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety. British Medical Journal 290, 12461248.CrossRefGoogle ScholarPubMed
Preskorn, H. & Denner, L. J. (1977). Benzodiazepines and withdrawal psychosis. Report of three cases. Journal of the American Medical Association 237, 3638.CrossRefGoogle ScholarPubMed
Raczynski, J. M., Thompson, J. K. & Sturgis, E. T. (1982). An evaluation of biofeedback assessment and training paradigms. Clinical Psychology Review 2, 337348.CrossRefGoogle Scholar
Rhodes, P. J., Rhodes, R. S. & McCurdy, H. H. (1984). Elimination kinetics and symptomatology of diazepam withdrawal in abusers. Clinical Toxicology 22, 371385.Google ScholarPubMed
Rickels, K. (1981). Are benzodiazepines overused and abused? British Journal of Clinical Pharmacology 11, 71s83s.CrossRefGoogle ScholarPubMed
Rickels, K. (1983). Benzodiazepines in emotional disorders. Journal of Psychoaclive Drugs 15, 4954.CrossRefGoogle ScholarPubMed
Rickels, K., Case, G. W., Downing, R. W. & Winokur, A. (1983). Long-term diazepam therapy and clinical outcome. Journal of the American Medical Association 250, 767771.CrossRefGoogle ScholarPubMed
Rickels, K., Case, G. W., Winokur, A. & Swenson, C. (1984). Longterm benzodiazepine therapy: Benefits and risks. Psychopharmacology Bulletin 20, 608615.Google ScholarPubMed
Rickels, K., Case, W. G., Schweizer, E. E., Swenson, C. & Fridman, B. S. (1986). Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacology Bulletin 22, 407415.Google ScholarPubMed
Roache, J. D. & Griffiths, R. R. (1986). Repeated administration of diazepam and triazolam to subjects with histories of drug abuse. Drug and Alcohol Dependence 17, 1529.CrossRefGoogle ScholarPubMed
Roehrs, T. A., Zorick, F. J., Wittig, R. M. & Roth, T. (1986). Dose determinants of rebound insomnia. British Journal of Clinical Pharmacology 22, 143147.CrossRefGoogle ScholarPubMed
Rosenberg, H. C. & Chiu, T. H. (1979). Decreased 3H-benzodiazepine binding is a specific response to chronic benzodiazepine treatment. Life Sciences 24, 803808.CrossRefGoogle Scholar
Rosenberg, H. C. & Chiu, T. H. (1981). Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. European Journal of Pharmacology 70, 453460.CrossRefGoogle ScholarPubMed
Rosenberg, H. C. & Chiu, T. H. (1982). An antagonist-induced benzodiazepine abstinence syndrome. European Journal of Pharmacology 81, 153157.CrossRefGoogle ScholarPubMed
Roth, T., Zorick, F. & Sickelsteel, J. (1981). Benzodiazepines and sleep and wakefulness. British Journal of Clinical Pharmacology 11, 315355.CrossRefGoogle ScholarPubMed
Roth, T., Roehrs, T. A. & Zorick, F. J. (1983). Pharmacology and hypnotic efficacy of triazolam. Pharmacotherapy 3, 137148.CrossRefGoogle ScholarPubMed
Rutherford, D. M. (1977). Rapid micro-method for the measurement of diazepam and desmethyldiazepam in blood plasma by gas–liquid chromatography. Journal of Chromatography 137, 439448.CrossRefGoogle ScholarPubMed
Ryan, G. P. & Boisse, N. R. (1983). Experimental induction of benzodiazepine tolerance and physical dependence. Journal of Pharmacology and Experimental Therapeutics 218, 701708.Google Scholar
Ryan, G. R. & Boisse, N. R. (1984). Benzodiazepine tolerance, physical dependence and withdrawal: Electrophysiologic study of spinal reflex function. Journal of Pharmacology and Experimental Therapeutics 231, 464471.Google Scholar
Saletu, B. (1982). Early clinical pharmacology of tranquillizers. In Psychopharmacology 1 Part 2, (ed. Hippius, H. and Winokur, G.), pp. 97122. Excerpta Medica: Amsterdam.Google Scholar
Salzman, C., Shader, R. I., Greenblatt, D. J. & Harmatz, J. S. (1983). Long v. short half-life benzodiazepines in the elderly – kinetics and clinical effects of diazepam and oxazepam. Archives of General Psychiatry 40, 293297.CrossRefGoogle Scholar
Sanchez-Craig, M., Kay, G., Busto, U. & Cappell, H. (1986). Letter. Lancet i, 388.CrossRefGoogle Scholar
Scharff, M. B. & Jacoby, J. A. (1982). Lorazepam – efficacy, side effects, and rebound phenomena. Clinical Pharmacology and Therapeutics 31, 175179.CrossRefGoogle Scholar
Schopf, J. (1983). Withdrawal phenomena after long-term administration of benzodiazepines: A review of recent investigations. Pharmacopsychiatry 16, 18.CrossRefGoogle ScholarPubMed
Schull, J. (1979). A conditioned opponent theory of Pavlovian conditioning and habituation. (ed. Bower, G. H.), pp. 5790. In The Psychology of Learning and Motivation, vol. 13. Academic Press: New York.Google Scholar
Schulz, R., Wuster, M., Krenss, H. & Herz, A. (1980). Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 285, 242243.CrossRefGoogle ScholarPubMed
Schuster, C. R. & Johanson, C. E. (1981). Environmental variables affecting tolerance development to anorectic drugs. (ed. Garratini, S. and Samanin, R.), pp. 6093. In Anorectic Agents: Mechanisms of Action and Tolerance. Raven Press: New York.Google Scholar
Sepinwall, J. and Cook, L. (1978). Behavioural pharmacology of anti-anxiety drugs. In Psychopharmacology, Vol. 13 (ed. Iversen, L. L., Iversen, S. D. and Snyder, S. H., pp. 345393. Plenum Press: New York.Google Scholar
Sepinwall, J. & Cook, L. (1980). Mechanism of action of the benzodiazepines: behavioural aspect. Federation Proceedings 39, 30243031.Google Scholar
Sepinwall, J., Gradsky, F. S. & Cook, L. (1978). Conflict behaviour in the squirrel monkey: effects of chlordiazepoxide, diazepam and N-desmethyl diazepam. Journal of Pharmacology and Experimental Therapeutics 204, 88102.Google Scholar
Seppala, T., Palva, E., Mattila, M. J., Korttila, K. & Shrotriya, R. C. (1980). Tofisopam, a novel 3, 4,-benzodiazepine: Multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol. Psychopharmacology 69, 209218.CrossRefGoogle Scholar
Shader, R. I. & Greenblatt, D. J. (1981). The use of benzodiazepines in clinical practice. British Journal of Clinical Pharmacology 11, 5s9s.CrossRefGoogle ScholarPubMed
Sher, P. K., Study, R. E., Mazzetta, J., Barker, J. L. & Nelson, P. G. (1983). Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam. Brain Research 268, 17111776.CrossRefGoogle ScholarPubMed
Shur, E., Petursson, H., Checkley, S. & Lader, M. (1983). Long-term benzodiazepine administration blunts growth hormone response to diazepam. Archives of General Psychiatry 40, 11051108.CrossRefGoogle ScholarPubMed
Seigel, S. (1975). Evidence from rats that morphine tolerance is a learned response. Journal of Comparative and Physiological Psychology 5, 498506.CrossRefGoogle Scholar
Siegel, S. (1983). Classical conditioning, drug tolerance and drug dependence. In Research Advances in Alcohol and Drug Problems, vol. 7, (ed. Israel, Y., Glaser, F. B., Kalant, H., Popham, P. E., Schmidt, W. and Smart, R. G.), pp. 7493. Plenum: New York.Google Scholar
Siegel, S. (1985). Drug-anticipatory responses in animals. In Placebo Theory, Research and Mechanisms (ed. White, L., Tursky, B. and Schwartz, G. E.), pp. 288305. The Guildford Press: New York.Google Scholar
Siegel, S. & MacRae, J. (1984). Environmental specificity of tolerance. Trends in Neuroscience 7, 140143.CrossRefGoogle Scholar
Siegel, S., Hinson, R. E. & Krank, M. D. (1981). Morphine-induced attenuation of morphine tolerance. Science 212, 15331534.CrossRefGoogle ScholarPubMed
Sieghard, W. & Karobath, M. (1980). Molecular heterogeneity of benzodiazepine receptors. Nature 286, 285287.CrossRefGoogle Scholar
Skegg, D. C. G., Doll, R. & Perry, J. (1977). Use of medicines in general practice. British Medical Journal i, 15611563.CrossRefGoogle Scholar
Skolnick, P., Marangos, P. J. & Paul, S. M. (1983). Endogenous ligands of the benzodiazepine receptor. In Anxiolytics: Neurochemical, Behavioural and Clinical Perspectives (ed. Malick, J. B., Enna, S. J. and Yamamura, H. I.), pp. 4153. Raven Press: New York.Google Scholar
Spinweber, C. L. & Johnson, L. C. (1982). Effects of triazolam (0·5mg) on sleep, performance, memory, and arousal threshold. Psychopharmacology 76, 512.CrossRefGoogle Scholar
Squires, R. F. (1983). Benzodiazepine receptor multiplicity. Neuropharmacology 22, 14431450.CrossRefGoogle ScholarPubMed
Squires, R. F. & Braestrup, C. (1977). Benzodiazepine receptors in rat brain. Nature 266, 732734.CrossRefGoogle ScholarPubMed
Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V. & Beer, B. (1979). Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors. Pharmacology, Biochemistry and Behaviour 10, 825830.CrossRefGoogle ScholarPubMed
Stephens, D. N. & Schneider, H. H. (1985). Tolerance to the benzodiazepine diazepam in an animal model of anxiolytie activity. Psychopharmacology 87, 322327.CrossRefGoogle Scholar
Syvalahti, E. K. G. & Kanto, J. H. (1975). Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man. International Journal of Clinical Pharmacology and Biopharmacology 12, 7482.Google ScholarPubMed
Tabakoff, B., Melchio, C. L. & Hoffman, P. L. (1982). Commentary on ethanol tolerance. Alcoholism: Clinical and Experimental Research 6, 252259.CrossRefGoogle ScholarPubMed
Tallman, J. F., Paul, S. M., Skolnick, P. & Gallager, D. W. (1980). Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science 207, 274281.CrossRefGoogle ScholarPubMed
Tallman, J. F., Mallorga, P., Thomas, J. W. & Gallager, D. W. (1981). GABA and benzodiazepine receptors. In Benzodiazepine Receptors (ed. Costa, E., Dichiara, G. and Gessa, G. L.), pp. 918. Raven Press: New York.Google Scholar
Tansella, M., Tansella, Z., Ferrario, L., Preziati, L., Tognoni, G. & Lader, M. (1978). Plasma concentrations of diazepam, nordiazepam and amylobarbitone after short-term treatment of anxious patients. Pharmakopsychiatrie Neuro-psychopharmakologie 11, 6775.CrossRefGoogle ScholarPubMed
Tedeschi, G., Griffiths, A. N., Smith, A. T. & Richens, A. (1985). The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. British Journal of Clinical Pharmacology 20, 361367.CrossRefGoogle ScholarPubMed
Thompson, D. M. (1974). Repeated acquisition of behavioural chains under chronic drug conditions. Journal of Pharmacology and Experimental Therapeutics 188, 700713.Google ScholarPubMed
Thompson, D. M. (1977). Development of tolerance to the disruptive effects of cocaine on repeated acquisition and performance of response sequences. Journal of Pharmacology and Experimental Therapeutics 203, 294302.Google Scholar
Thompson, T. (1984). Behavioural mechanisms of drug dependence. Advances in Behavioural Pharmacology 4, 145.CrossRefGoogle Scholar
Ticku, M. K. (1983). Benzodiazepine-GABA receptor-ionophore complex: Current concepts. Neuropharmacology 22, 14591470.CrossRefGoogle ScholarPubMed
Ticku, M. K. (1985). Allosteric modulation of benzodiazepine GABA-receptor-ionophore complex by nonbenzodiazepines. Psychiatry and Biological Therapy 18, 4748.Google Scholar
Ticku, M. K. & Maksay, G. (1983). Convulsant/depressant site of action at the allosteric benzodiazepine-GABA receptor ionophore complex. Life Sciences 33, 23632375.CrossRefGoogle ScholarPubMed
Tognoni, G., Gomeni, R., Demaio, D., Alberti, G. G., Franciosi, P. & Scieghi, G. (1975). Pharmacokinetics of n-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. British Journal of Clinical Pharmacology 2, 227232.CrossRefGoogle ScholarPubMed
Treit, D. (1985). Evidence that tolerance develops to the anxiolytic effect of diazepam in rats. Pharmacology, Biochemistry and Behaviour 22, 383387.CrossRefGoogle Scholar
Tyrer, P., Owen, R. & Dawling, S. (1983). Gradual withdrawal of diazepam after long-term therapy. Lancet i, 14021406.CrossRefGoogle Scholar
Tyrer, P., Rutherford, D. & Huggett, T. (1981). Benzodiazepine withdrawal symptoms and propranolol. Lancet i, 520522.CrossRefGoogle Scholar
Tyrer, P., Treasaden, I., Moreton, K., Riley, P., Flanagan, R. J. & Dawling, S. (1984). Value of serum diazepam and nordiazepam measurements in anxious patients. Journal of Affective Disorders 7, 110.CrossRefGoogle ScholarPubMed
Vellucci, S. & File, S. (1979). Chlordiazepoxide loses its anxiolytic action with long-term treatment. Psychopharmacologia 21, 17.Google Scholar
Vogel, G. W., Barker, K. & Gibbons, P. (1976). A comparison of the effects of flurazepam 30 mg and triazolam 0·5.mg on the sleep of insomniacs. Psychopharmacology 47, 8186.CrossRefGoogle Scholar
Walsh, J. K., Schweitzer, P. K. & Parwatikar, S. (1983). Effects of lorazepam and its withdrawal on sleep, performance and subjective state. Clinical Pharmacology and Therapeutics 34, 496500.CrossRefGoogle ScholarPubMed
Waterhouse, B. D., Moises, H. C., Geller, H. M. & Woodward, D. J. (1984). Comparison of norepinephrine- and benzodiazepineinduced augmentation of purkinje cell responses to GABA. Journal of Pharmacological and Experimental Therapeutics 228, 257267.Google ScholarPubMed
Wesson, D. R. & Smith, D. E. (1982). Low dose benzodiazepine withdrawal syndrome: Receptor site mediated. California Society For the Treatment of Alcoholism and Other Drug Dependencies News 9, 15.Google Scholar
Wilkinson, M., Moger, W. H. & Grovestine, D. (1980). Chronic treatment with valium (diazepam) fails to affect the reproductive system of the male rat. Life Sciences 27, 22852291.CrossRefGoogle ScholarPubMed
Williams, E. J. (1949). Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Research 2, 149156.Google Scholar
Winer, B. (1971). Statistical Principles in Experimental Design, 2nd edn. McGraw-Hill: New York.Google Scholar
Winokur, A., Rickels, K., Greenblatt, D. J., Snyder, P. J. & Schats, N. J. (1980). Withdrawal reaction from long-term administration of diazepam. Archives of General Psychiatry 37, 101105.CrossRefGoogle ScholarPubMed
Young, W. S. III, Niehoff, D., Kuhar, M. J., Beer, B. & Lippa, A. S. (1981). Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry. Journal of Pharmacological and Experimental Therapeutics 216, 425430.Google ScholarPubMed
Zipursky, R. B., Baker, R. W. & Zimmer, B. (1985). Alprazolam withdrawal delirium unresponsive to diazepam: Case report. Journal of Clinical Psychiatry 46, 344345.Google ScholarPubMed